The ALS Association Help Find A Cure


Research news

The ALS Association provides the latest research news & information relevant to the fight against this disease through press releases, blog posts, research webinars, newsletters and more.

Latest research news & information

Keep up-to-date on what’s going on in the world of ALS research and learn more about ALS research.

[More News Features]

New Protein Target Emerges for C9orf72 the Most Common Genetic Form of ALS

The ALS Association in Partnership with ALS Finding a Cure® and Massachusetts General Hospital Invests $3.6 Million to Expand the NeuroBANK™ Program

Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS

View All Latest News

ALS Association research webinars

Every month, The ALS Association invites a leading ALS expert to come talk about his or her area of expertise in our research webinar series. Register for an upcoming webinar below.

Genomic Translation for ALS Care (GTAC study): Envisioning the Precision Medicine Future for ALS

Tuesday, October 11, 2016, 4:00 p.m. EST

Speaker: Matthew Harms, Ph.D., Director of GTAC and Assistant Professor of Neurology at Columbia University Medical Center

Genomic Translation for ALS Care (GTAC) is a collaboration with Biogen and Columbia University Medical Center (CUMC) to better understand how different genes contribute to various clinical forms of ALS. This will in turn help researchers design better, more focused clinical trials for the development of more effective treatments. This kind of precision medicine, in which treatment is tailored to each person’s unique genetic makeup, will be effectively applied to ALS. On October 11th, join us to learn more about this exciting strategic initiative supported by The ALS Association.

Register Now

ALS: Light from SOD1 Protein – Protein Interactions

Tuesday, December 13, 2016, 4:00 p.m. EST

Speaker: Mel Reichman, Ph.D., Director, LIMR Chemical Genomics Center (LCGC), Senior Investigator, Lankenau Institute for Medical Research (LIMR)

Certain genetic changes in super oxide dismutase-1 (SOD1), the second most common form of inherited ALS, cause this protein composed of two parts (a dimer) to fall apart into individual pieces (monomers). These SOD1 monomers can abnormally clump together in motor neurons during ALS disease. Join us to learn about Dr. Reichman’s research to develop new ways to discover novel ALS drugs that stabilize SOD1 dimers. This includes a high-throughput screening technique, which could reveal unexpected, safe combinations of FDA-approved drugs to treat ALS.

Register Now

View All Webinars

Research ALS Today

The ALS Association produces a scientific newsletter twice per-year to highlight major advances in the field of ALS research. The current issues includes the following topics and is available for download:

  • Nuclear Transport: A New Therapeutic Target for ALS?
  • Sheila Essey Award
  • Clinical Research Fellowships
  • Assistive Technology Challenge
  • TDP-43 Biomarker Challenge
  • ALS Research Forum partnership with The ALS Association
  • Journal News

The ALS Association blog


On our blog, The ALS Association, or one of our guest bloggers, discusses breaking research news in a more casual, easy-to-understand format than you may find in your average scientific journal.

View All Blog Posts

Call for abstracts & participation

Throughout the year, The ALS Association offers multiple funding opportunities for scientists and clinicians made possible through support from our generous donors.

The ALS Assistive Technology Challenge

The ALS Assistive Technology Challenge, a joint initiative by The ALS Association and Prize4Life, is offering a $400,000 award for the development of flexible, accessible technology to help people with ALS communicate with ease.

Learn more
Connect With Us

Sign up for news on the latest advances in ALS research.

For scientists looking for more information about grant opportunies and meetings, contact

Follow Us
ALS Association Blog

Read the latest ALS news and how your support makes an impact!

Powered by Blackbaud
nonprofit software